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ABSTRACT Small angle x-ray scattering has been used to investigate the structure of synaptoneurosomal (SNM) membranes
from rat cerebral cortex. Electron micrographs of the preparation showed SNM with classical synaptic appositions intact,
other vesicles, occasional mitochondria, and some myelin. An immunoassay for myelin basic protein placed the myelin
content of normal rat SNM at <2% by weight of the total membrane present. X-Ray diffraction patterns showed five diffraction
orders with a unit cell repeat for the membrane of 71 to 78 A at higher hydration states. At lower hydration, 11 orders
appeared; the unit cell repeat was 130 A, indicating that the unit cell contained two membranes. Electron density profiles for
the 130-A unit cell were determined; they clearly showed the two opposed asymmetrical membranes of the SNM vesicles.
SNM membrane/buffer partition coefficients (Kp) of imidazobenzodiazepine and 1,4-dihydropyridine (DHP) calcium channel
drugs were measured; Kp's for DHP drugs were approximately five times higher in rabbit light sarcoplasmic reticulum than in
SNM. Ro 15-1788 and the DHP BAY K 8644 bind primarily to the outer monolayer of vesicles of intact SNM membranes.
Nonspecific equilibrium binding of Ro 15-1788 occurs mainly in the upper acyl chain of the bilayer in lipid extracts of SNM
membrane.
INTRODUCTION
Our studies of rat cerebral cortical synaptoneurosomal
(SNM) membranes (1) were undertaken to test the
hypothesis that the location of nonspecific binding of a
drug molecule in the cell membrane lipid bilayer is the
key to understanding how the drug molecules approach
the specific binding site on a membrane-bound receptor.
Our broad interest is in the complex effects of ethanol
on brain membranes. Although ethanol does not bind to a
specific site in brain membranes, ethanol has a profound
effect on chloride ion flux (2). Presumably, ethanol acts
through the y-aminobutyric acid (GABA)A/benzodiaz-
epine receptor complex, which contains a chloride chan-
nel and a benzodiazepine binding site as well as binding
sites for GABA and picrotoxin. The imidazobenzodiaz-
epine Ro 15-4513, a benzodiazepine receptor partial
inverse agonist, can block the effect of ethanol on chloride
flux in SNM membranes (3). Ro 15-1788 is a benzodiaz-
epine receptor antagonist which is closely related to Ro
Address correspondence to Dr. J. Moring, Biomolecular Structure
Analysis Center, University of Connecticut Health Center,
Farmington, CT 06032.
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dihydropyridine; DPPC, dipalmitoylphosphatidylcholine; DOPC, diole-
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15-4513 (Fig. 1). Because Ro 15-4513 blocks the effects
of ethanol on chloride flux, we have chosen to work on it
and the related antagonist.
In other work on the effects of ethanol, Littleton and
Little (4) and Dolin et al. (5) have shown that the calcium
channel associated with the 1,4-dihydropyridine (DHP)
calcium channel receptor is involved in developing depen-
dence on ethanol. Symptoms mimicking ethanol with-
drawal can be induced by the calcium channel agonist
BAY K 8644 (4). Moreover, ethanol withdrawal symp-
toms can be prevented by administration ofDHP calcium
channel antagonists (6).
Our ultimate aim is to discover exactly how the
imidazobenzodiazepine and DHP drugs interact with
their respective receptors and with other components of
the SNM, and how acute or chronic administration of
ethanol perturbs these interactions. As the first step, using
standard methods (7-14) for the analysis of membrane
structure by x-ray diffraction, we have investigated the
nonspecific equilibrium binding location of BAY K 8644
in the intact membrane, and of Ro 15-1788 in the intact
membrane and in a bilayer composed of extracted lipids
from SNM membrane. As part of this work, we have
determined partition coefficients between SNM mem-
branes and buffer for Ro 15-1788 and for the DHP's BAY
K 8644 and nimodipine.
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FIGURE 1 Chemical structures of drugs. (Top) BAY K 8644, a
1,4-dihydropyridine calcium channel agonist. (Bottom) The imidazoben-
zodiazepines Ro 15-4513, a benzodiazepine receptor partial inverse
agonist, and Ro 15-1788, a benzodiazepine receptor antagonist.
METHODS
SNM vesicle preparation
SNM membrane vesicles from rat cerebral cortex were prepared
essentially by the method of Hollingsworth et al. (1) with some
modifications. The buffer contained 20mM Hepes,9 mM Tris, 118 mM
NaCl, 4.7 mM KCI, 1.18 mM MgSO4, and 2.5 mM CaCl2, pH 7.4. Any
remaining red blood cells (RBC) were removed by centrifugation of the
vesicle suspension in an Eppendorf Micro Centrifuge 5415 (Brinkman
Instruments, Inc., Westbury, NY) at 3,500 rpm (1000 g) for 10 min at
80C in 1.5 ml polyethylene tubes, after which the portions of the tubes
containing the RBC were cut off and the remaining pellets were
resuspended in buffer to their original volume. The RBC-free prepara-
tion was then lysed in 10 vol of cold distilled deionized water and
centrifuged at 5,220 g (8,000 rpm) for 10 min at 8°C; the pellet was
resuspended in sufficient buffer to restore its original volume. Protein
content for each preparation was determined by the method of Lowry et
al. (15). Phospholipid concentration was estimated from phosphate
content determined by the method of Chen (16).
Membrane multilayer x-ray
diffraction samples
Multilayer samples of intact SNM membranes for small-angle x-ray
scattering were prepared by centrifuging (L8-55m ultracentrifuge,
SW28 rotor, Beckman Instruments, Inc., Palo Alto, CA) a volume of
SNM preparation containing 150 ,ug protein (with or without added
drug) at g., = 1,000 (5,000 rpm) for 15 min at 50C in a lucite
sedimentation cell (17) (University of Pennsylvania Biomedical Instru-
mentation Shop). If a drug was added, BAY K 8644 was added as a
10-mM solution in ethanol; Ro 15-1788 was added as a 1.3-mM solution
in the buffer used for making the vesicle suspension (final concentrations
before centrifugation and removal of supernatant were 3 mM and 0.65
mM, respectively). If BAY K 8644 was added to a sample, an equal
amount of ethanol was added to its control. The pellet was deposited on
aluminum foil which was then affixed to a curved glass support (radius
of curvature 2.5 cm). The sample was equilibrated over a saturated
solution of a salt selected to maintain a given relative humidity and
hence a constant hydration state of the multilayer (9).
SNM lipid experiments
Lipids were extracted from SNM preparations after the lysing step by
the method of Folch et al. (18), using 2:1 chloroform/methanol at a
solvent/sample volume ratio of 50:1. Cholesterol content of the lipid
extracts was assayed enzymatically by the method of Heider and Boyett
(19) as modified by Chester et al. (20).
Thin films were made in test tubes from the extracted lipids by the
method of Bangham et al. (21). The solvent was first dried off under
nitrogen while the extract was vortexed. The tubes were then held under
vacuum for at least 30 min to remove residual solvent. Vesicles were
formed when buffer (2mM Hepes, 10mM NaCl) or Ro 15-1788/buffer
solution was added to the tubes as they were being vortexed under
nitrogen. The final concentration of Ro 15-1788 in the vesicle suspension
was 0.5-0.8 mM.
Lipid multibilayer samples for x-ray diffraction were then made by
pipetting a volume of vesicle suspension sufficient to contain 150 gg lipid
into a lucite sedimentation cell (17) (University of Pennsylvania
Biomedical Instrumentation Shop) and centrifuging the vesicles onto
aluminum foil at g., = 81,000 (25,000 rpm) for 1 h at 50C in a Beckman
Instruments, Inc. L8-55m ultracentrifuge (SW28 rotor). The superna-
tant was removed immediately after centrifugation. The pellet was
mounted on a curved glass support (radius of curvature 2.5 cm) for x-ray
diffraction and allowed to equilibrate over a saturated solution of a salt
selected to maintain a given relative humidity.
Other multilayer diffraction samples of extracted lipids were made by
the "spin-dry" technique by a variation (22) of the method of Clark et
al. (23), in which all volatile fluids in the sample are evaporated
completely by the centrifuge vacuum system during sedimentation. The
final composition of the sample can be precisely controlled in this way.
The lipid vesicle suspension (150 Ag lipid) is first subjected to a prespin
at 30C at g., = 81,000 (25,000 rpm) for 30 min (lucite sedimentation
cell, Beckman Instruments, Inc. L8-55m, ultracentrifuge, SW28 rotor,
2 ml water cushion in buckets). For the dehydration step, caps which
have a 100-Mm pinhole are used on the buckets (no water cushion).
Centrifugation under vacuum at ga. = 30,000 (15,000 rpm) at 30C for
31/-5 h is sufficient to dehydrate the 50 A samples completely. In some
experiments Ro 15-1788 was added during the formation of the lipid
vesicles as explained above, except that the drug was added to the buffer
from a 10-mM ethanol stock solution before the drug/buffer solution
was added to the thin lipid film. The final amount of the drug in the
diffraction samples was 1 mol drug/30 mol lipid.
X-ray diffraction
Diffraction data were collected using an Elliot GX 18 rotating anode
microfocus generator (Marconi Avionics) supplying Cu K. radiation
(A = 1.54 A) in conjunction with a fixed geometry beamline consisting
of a single Franks mirror providing line focus at the detection plane,
vertical and horizontal limiting slits, a nickel filter, the curved specimen,
a tungsten beamstop, and electronic detection. The beam height at the
specimen was -1 mm. Data collection was carried out with a Braun
one-dimensional position-sensitive proportional counter (Innovative Tech-
nology, Inc., Newburyport, MA). Data were transferred to a VAX 8200
(Digital Equipment Corporation, Maynard, MA) for reduction and
analysis.
For data on extracted lipids, diffraction orders were integrated by
summing the x-ray counts between channels judged to be within the
background region on either side of the order, and subtracting a
trapezoidal background area determined by applying a linear fit to the
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background on either side of the order. A linear s-correction was made to
correct for differences in beam geometry at various regions of the curved
sample. Intensities were phased by the swelling method (24) using a
range of relative humidities from 84% to 98%. Structure factor plots
were constructed. Because the unit cell for the extracted lipids must be
centrosymmetric, all phases were either 0 or r. The higher orders for
which the phases were uncertain were phased by calculating electron
density profiles for all of the possible phase combinations and selecting
the set of phases which gave a reasonable bilayer profile.
Reduction of data collected on intact membrane multilayer samples
at relative humidities higher than 84% (unit cell d - 72 A) was similar to
that for extracted lipid data. Centrosymmetry was assumed and phases
were obtained in the same manner as for lipid data. A modification of the
method used by Blaurock and King (13) was used to ascertain that the
phases were close to those for a centrosymmetric unit cell. The phase of
the first order was fixed at ir; phases of other orders were varied as
follows: second order, 02 = Xr + nr/8, n = 1, 2,. .., 8; fourth order,
+4 = Ir + nir/8, n = 0, ± 1, ±2, . . .±, 8. The third order is either very
small or equal to zero in these data sets; it was assigned an intensity of
zero. Electron density profiles were calculated using each phase of the
second order combined with each phase of the fourth order in turn.
Structure factor moduli were calculated from these electron density
profiles and compared with those derived from the swelling studies.
For diffraction data with a d-spacing of - 130 A (relative
humidity <84%), a sum of exponentials was fitted to the background
region and subtracted. Diffraction orders were integrated by summing
the x-ray counts between what were judged to be the limits of each peak.
Linear s-corrections were made to correct for differences in beam
geometry at various regions of the curved sample. Box refinements were
carried out using the method of Stroud and Agard (25). The multilayer
and unit cell Patterson functions were calculated (assuming centrosym-
metry) and direct deconvolution of the unit cell Patterson was carried
out as described by Lesslauer et al. (26) and Schwartz et al. (27). The
Fourier transform of the resulting electron density profile was calculated
and sampled at intervals of h/d (h = 1, 2,. . ., 11) (d = 130.7 A) to
obtain phases for a centrosymmetric unit cell. These phases were then
used with the experimental intensity data to calculate an electron
density profile for the 130-A unit cell.
X-Ray scattering from dispersions of membrane vesicles was carried
out using either a point-focus beam (Searle x-ray camera with two
Franks mirrors; Baird and Tatlock, Romford, England) or a line focus
beam (single Franks mirror) with the beam height set equal to the beam
width. Dispersions of lysed SNM in buffer with protein concentrations
of -10-14 mg/ml were sealed in quartz capillaries (1.5 mm i.d.) and
exposed to the x-ray beam for periods from 18 h to 3 d. Data were
recorded on film. Films were scanned on a Zeineh model SL-2DUV soft
laser densitometer (Biomed Instruments, Inc., Fullerton, CA); data
were transferred to a VAX 8200 computer system (Digital Equipment
Corporation, Maynard, MA) for reduction and analysis. Background
was removed by exposing a blank (capillary filled with buffer) to the
x-ray beam for the same length of time and subtracting the blank from
the data.
Electron microscopy
Samples of original, RBC-free, and lysed SNM preparations were
prepared for thin sectioning for transmission electron microscopy by
centrifugation in an Eppendorf microcentrifuge for 5 min at 1000 g
(3,500 rpm) at 80C. The pellets were fixed first in 2% glutaralde-
hyde/I% tannic acid/100 mM sodium cacodylate buffer, pH 7.2, for 1.5
h and given three 15 min washes in sodium cacodylate buffer. The pellets
were then fixed in 2% osmium tetroxide/ 100 mM sodium cacodylate pH
7.2, washed as above, and dehydrated through 50, 70, 90, 95, and 100%
ethanol at 30 min per step. After two 30 min washes in propylene oxide,
the pellets were agitated overnight in capped vials in 1:1 Polybed
80/propylene oxide. The resin was changed three times the next day and
agitated again overnight. The pellets were then placed in a mold in a
60°C oven for 2 d. Sections were made using a Sorvall MT2B microtome
(Dupont Instrument Systems, Wilmington, DE) with a diamond knife.
Silver sections (80 ± 10 nm) were immersed for 20 min in 2% uranyl
acetate, washed, and finally immersed for 20 min in Reynolds lead
citrate.
Immunoassay for myelin basic
protein
A quantitative immunoassay for myelin basic protein was carried out by
a method based on the Western blot. Mouse 14 kDa myelin basic protein
(MBP) was used as the standard. Six serial dilutions (1:2) in 0.5 mM
Tris, 5% wt/vol sodium dodecyl sulfate, pH -8 (dilution buffer), of the
samples and standard were made. The solutions were adsorbed on
Immobilon PVDF Transfer Membrane (Millipore Corp., Bedford, MA)
contained in a 96-well filtration apparatus (Schleicher and Schuell, Inc.,
Keene, NH). Before blotting, the Immobilon had been equilibrated in
dilution buffer. After blotting, the membrane was rewetted in methanol
for 1-2 s and briefly rinsed with water. The remaining protein sites were
blocked by incubating in blocking buffer composed of 5% (wt/vol)
bovine serum albumin (BSA) in tris buffered saline (TBS) (10 mM
Tris/HCl pH 7.4,0.9% NaCl) at 370C for 1 h with gentle agitation. The
blot was rinsed four times with wash solution (0.1% [wt/vol] BSA in
TBS). The blot was then incubated with primary antibody (polyclonal
rabbit a MBP) which had been diluted 1:200 with antibody incubation
solution, for 2 h at room temperature with gentle agitation. Antibody
incubation solution is 1% BSA (wt/vol), 0.05% (vol/vol) Tween-20 in
TBS. The blot was rinsed four times (all rinses in this procedure are 5
min each) with wash solution, then incubated for two h at room
temperature with the secondary antibody (goat a-rabbit IgG, horserad-
ish peroxidase conjugated) diluted 1:500 in antibody incubation solu-
tion. The blot was rinsed four times with wash solution, then incubated
with the horseradish peroxidase substrate 4-chloro-1-naphthol solution
as follows: 30 mg 4-chloro-1-naphthol (Sigma Chemical Co., St. Louis,
MO) was dissolved in 10 ml methanol which had been cooled to -200C.
This solution was kept at - 200C. First 50 ml TBS and then 30 Ml of 30%
hydrogen peroxide (Sigma Chemical Co.) were mixed with this solution
just before the blot was ready for staining. The substrate solution was
mixed for 1 min and then added to the blot immediately after the blot
had been removed from the wash solution. The blot was incubated with
the substrate solution at room temperature with constant agitation for
-10 min until the degree of staining was appropriate relative to the
background color. The staining reaction was stopped by rinsing in water
followed by drying the blot. The blot was dried between sheets of
blotting paper and stored away from light. It was scanned using a
Zeineh model SL-2DUV soft laser densitometer (Biomed Instruments,
Inc., Fullerton, CA).
Partition coefficient measurements
Filtration method
Partition coefficients of imidazobenzodiazepine and DHP drugs into
intact SNM membranes were experimentally measured using vacuum
filtration as previously described (28). The filtration method was
selected for this study because of its ability to separate rapidly and
efficiently membrane-bound radioligand from free radioligand. Filtra-
tion was accomplished using a Brandel cell harvester (Brandel, Inc.,
Gaithersburg, MD). Using vesicles radiolabeled with '4C-DOPC, we
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were able to measure accurately the amount of membrane phospholipid
retained on the filter during the filtration process.
To obtain total nonspecific binding, the filters for these experiments
were not washed. Reaction mixtures containing drug, but no membrane,
were used to correct the total nonspecific binding for binding of drug
directly to filters. All filters were counted for radioactivity. The amount
of drug in the filtrate was determined by subtracting the number of
moles of drug bound to the membrane from the total number of moles of
drug added to the reaction mixture. This information, along with the
total number of moles of drug in the reaction mixture and the amount of
lipid present, corrected for the recovery of membrane on the filters,
allowed membrane/buffer partition coefficients to be calculated for each
trial.
The concentration of phospholipid in the incubation reaction mixture
was fixed at 25.6 MM (20 ug/ml). Radiolabeled drug was added to
vesicles of intact membrane to produce a final concentration of drug in
the reaction mixture of 2.5 x 10-'0M to 1.88 x 10'- M. Membrane/
buffer partition coefficients were calculated using the following equa-
tion: Kp = (grams of drug bound to membrane/grams of membrane
phospholipid)/(grams of drug in supernatant/grams of buffer).
Centrifugation method
Partition coefficients of DHP drugs between light sarcoplasmic reticu-
lum (LSR) membrane and buffer were determined by a centrifugation
method. SNM membrane vesicles were suspended (12 ug/ml) in a pH
7.3 buffer (10mM Tris, 150mM NaCI) containing a known concentra-
tion of 3H-labeled drug (28). The samples were centrifuged in polyethyl-
ene microcentrifuge tubes (400 Md) in a Beckman Instruments, Inc.
SW28 swinging bucket rotor for 1 h at g,v = 81,000 (25,000 rpm) at
5°C. Control tubes contained the same reaction mixtures, but were not
centrifuged. The tips of the centrifuge tubes containing the membrane
pellets were cut off, blotted dry, and placed in scintillation fluid to be
counted for 3H radioactivity. The total pellet counts (centrifuged
membranes) were corrected by subtracting the counts from blank
controls (same size tip of tube which contained uncentrifuged reaction
mixture) to give the counts due to drug associated only with membranes.
To account for the labeled drug remaining in the supernatant, a 2O-jsl
aliquot was taken from the supernatant in each centrifuge tube; then the
tubes were drained, cut, and assayed for radioactivity. All labeled drug
added to each tube could be accounted for as distributed among the
centrifuged pellets, the walls of the tube, and the supernatant.
Membrane partition coefficients were calculated as above. The
amounts of drug in the pellets (bound to membrane) and in the
supernatants were determined as described above. The amounts of lipid
were corrected for the recovery of membrane in the pellets after
centrifugation.
RESULTS
Characteristics of the SNM
preparation
Protein contents of the original rat SNM preparations
ranged from 11.8 to 21.4 mg/ml. The corresponding
phospholipid contents ranged from 12.7 to 18.1 ,umol/ml.
The highest phospholipid/protein ratio was 1.08 and the
lowest 0.74 umol/mg. For the RBC-free unlysed and
lysed preparations, the concentrations were somewhat
lower. Electron micrographs of some original, RBC-free
unlysed, and lysed samples all showed SNM images with
classical synaptic appositions intact, other vesicles, occa-
sional mitochondria, and some nerve myelin (Fig. 2).
An immunoassay for myelin basic protein showed that
<2% by weight of the total membrane present in both the
lysed and unlysed SNM preparations was myelin. X-Ray
scattering experiments on dispersions of rat SNM mem-
branes vesicles showed no Bragg scattering corresponding
to d spacings of -150-160 A, the spacing that would be
expected for intact myelin (24). The films showed a weak
ring of Bragg-like diffraction (d spacing = 76 A); this
could be attributable to a myelin-like multilayer struc-
ture.
Characteristics of shiverer mouse
SNM
To show that the diffraction was not due to nerve myelin,
SNM preparations were made from myelin-free shiverer
mice. These mice, which are homozygous for the shi
mutation, make little or no myelin basic protein and
therefore do not form well-ordered myelin (29). The
phospholipid/protein ratio was 1.3 ,mol/mg for both the
RBC-free unlysed and lysed mouse SNM preparations.
Electron micrographs were similar to those of the rat
SNM preparations, except for an almost total lack of
well-ordered myelin (Fig. 3). No myelin at all was de-
tected by an immunoassay for myelin basic protein in
either shiverer mouse SNM or whole brain homogenate.
Diffraction from intact SNM
membranes
Relative humidities from 98% to 76% were used for the
membrane diffraction experiments, but not all of these
humidities gave useful results. The highest quality diffrac-
tion was obtained at relative humidities of 91%, 87%, and
84%. Although electron micrographs of lysed and unlysed
rat SNM preparations appeared similar, the diffraction
patterns were different. Unlysed samples generally showed
fewer diffraction orders than lysed samples, and the peaks
were broader, although the d spacing was about the same.
Therefore, only lysed preparations were used for diffrac-
tion after the preliminary experiments were finished.
Most preparations yielded five sharp diffraction orders at
relative humidities above 84%. A typical diffraction
pattern is shown in Fig. 4. Patterns which were chosen for
further analysis were those having relatively sharp, sym-
metrically shaped peaks with the intensity between the
peaks as near as possible to background level. Patterns
having extra peaks which did not index, patterns having
very broad peaks (due to disorder in the sample), and
patterns having split peaks or peaks with shoulders
(indicating phase separation) were rejected.
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FIGURE 2 Electron micrographs. Rat cerebral cortical SNM preparations. (a) Unlysed, two synaptoneurosomes are marked by arrows. (b) Lysed, at
lower magnification. Note myelin.
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FIGURE 3 Electron micrographs. Shiverer mouse cerebral cortical synaptoneurosome preparations. Note lack of myelin. (a) Synaptoneurosomes
from unlysed preparation at high magnification. The outer leaflet of the membrane is more densely stained than the inner leaflet, e.g., in the region
indicated by the arrow. (b) Lysed.
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FIGURE 4 X-Ray diffraction patterns from a typical rat cerebral cortical synaptoneurosome preparation at 91% relative humidity and 11.0°C
(d = 73.3 A). The diffraction orders are numbered. Data are shown before Lorentz and background correction. (a) Diffraction from lysed
preparation. (b) Orders 2-5 of the diffraction pattern scaled up.
n I
Moring et al. Drug
Diffraction patterns, d spacings, and calculated elec-
tron density profiles for the shiverer mouseSNM prepara-
tions were similar to those found for rat SNM prepara-
tions. Centrosymmetric electron density profiles and d
spacings obtained from the shiverer mouse preparations
were indistinguishable from those from ratSNM prepara-
tions. The results of the diffraction experiments on shiv-
erer mouse SNM indicated that the diffraction from the
rat SNM preparations was not due to myelin.
For diffraction patterns recorded at relative humidities
above 84%, a modification of the phasing method used by
Blaurock and King (13) (see Methods) indicated that the
phases are close to those for a centrosymmetric unit cell.
The phase of the second order, 42' must be within ±+r/4 of
01. Experiments using x-ray scattering from dispersions of
SNM vesicles produced no data beyond 0.026 A-1, a
value corresponding to the location of the second order of
Bragg diffraction. These data were not good enough to be
useful for determining phases. For these reasons phases
determined from a swelling study were used to calculate
centrosymmetric electron density profiles only for compar-
ison purposes. These electron density profiles were charac-
teristic of a typical membrane bilayer with protein contri-
bution and with d spacings of 71-78 A, depending on
relative humidity. The scattering films also showed a
weak ring of Bragg-like diffraction at a d spacing of
76 A; this would be due to multilamellar vesicles or
multilamellar fragments of membrane, possibly myelin
(1 1).
At 84% relative humidity, additional peaks appeared,
doubling the d spacing (-130 A). The doubling was
reversed upon raising the relative humidity; therefore no
permanent change in the membrane structure had oc-
curred. A diffraction pattern at 84% relative humidity is
shown in Fig. 5. At 76% relative humidity, additional
small peaks appeared which had lattice spacings different
from that of the membrane, indicating phase separation.
The pattern at 84% relative humidity represents diffrac-
tion from a new unit cell with a repeating unit consisting
of two membranes (see Discussion).
Because of the change in structure between 87% and
84% and the phase separation at 76%, it is impossible to
do an extensive swelling study to determine phases for the
double membrane diffraction pattern. However, other
analyses indicate that this diffraction is due to a centrosym-
metric unit cell containing two membranes, for which
another method of phase determination can be used. The
multilayer Patterson function for the diffraction pattern
at 84% relative humidity is shown in Fig. 6 a; its repeat
distance is 130 A. Correlations are observed between sets
of high electron density regions (headgroups) at 65 A, low
electron density regions (methyl troughs) at 65 A, and
between headgroups and methyl troughs at 32.5 A; these
correlations indicate a unit cell containing two mem-
branes. The multilayer Patterson decays within 1250 A;
the envelope is nearly linear in the region from 0 to 2 d.
Because the decay indicates that there is disorder in the
sample and because the Patterson function approaches
zero after about eight repeating units, the box refinement
technique is suitable for determining an electron density
profile (25). An exhaustive series of box refinements using
several types of trial functions and various box sizes was
carried out. Best results were obtained from a trial
function constructed from many repeats of an electron
density profile obtained by the direct deconvolution meth-
ods described below. The constructed "multilayer" was
multiplied by a half Gaussian to simulate increasing
disorder. The trial function and the resulting electron
density profile are shown in Fig. 7. The optimal box size
was 1,000 A, although box sizes from 800 to 1,200 A were
suitable. Results from other types of trial functions
(boxes, cosines, sums-of-cosines, etc.) were similar. The
box refinements yielded electron density profiles character-
istic of multiple repeats of a unit cell containing two
membranes: a repeat distance of -130 A, peaks corre-
sponding to headgroups separated by -65 A, and troughs
separated by -65 A. The distances between the centers of
mass of the peaks varied by at most ±4 A from 65 A; most
refinements gave peak-to-peak distances within 2 A of
65 A. These distances indicate that the unit cell is nearly
centrosymmetric.
To determine phases for the two-membrane unit cell
data, a unit cell Patterson function (Fig. 6 b) was calcu-
lated from the multilayer Patterson. Direct deconvolution
of the unit cell Patterson function (26, 27) yielded an
electron density profile characteristic of a double mem-
brane (Fig. 8). The direct deconvolution technique tends
to generate large errors, but we used the method only for
the purpose of generating sets of phases. Phases obtained
by sampling the Fourier transform of this profile at
intervals of h/d (h = 1, 2, . . . 11) were applied to the
experimentally determined intensity data to calculate an
electron density profile for a centrosymmetric unit cell
(Figs. 9 and 10). Error analysis as conducted for the
extracted lipid preparations, below, could not be done
because a swelling series was impossible. The errors in the
double membrane electron density profiles, however, are
unlikely to be larger than ± 5% at any point in the profile.
SNM extracted lipid preparations
The diffraction patterns for the extracted lipids showed
six orders, and the electron density profile had a typical
bilayer structure (Fig. 11 a). When Ro 15-1788 was
added to vesicles of extracted SNM lipids prepared by the
"spin-dry" method (22), comparison of the electron
density profile at 84% relative humidity with that of lipids
without added drug showed an increase in electron
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FIGURE 5 X-Ray diffraction pattern from rat synaptoneurosomes. (a) Diffraction pattern at 84% relative humidity, 10°C, d = 130.7 A. Data are
shown before Lorentz and background correction. The pattern is due to a unit cell containing two membranes. (b) Diffraction orders 5-11 scaled up.
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FIGURE 6 Patterson functions. (a) The multilayer Patterson function
calculated from the diffraction intensities observed at 84% relative
humidity and 100C from an SNM membrane sample without added
drug. The repeat distance is -130 A. (b) The unit cell Patterson
function. Note that it goes to zero at the edges.
density in the upper acyl chain region of the bilayer
(Fig. 11 a). We believe that this electron density repre-
sents the location of the drug in the bilayer. Larger d
spacings (60-72 A) were observed for samples made by
other than the "spin-dry" method. The quality of diffrac-
tion was poorer; at most five orders of diffraction were
observed.
Although the differences between the electron density
FIGURE 7 Box refinement. (a) This trial function was constructed from
many repeats of the electron density profile resulting from the direct
deconvolution of the unit cell Patterson function. The constructed
"multilayer" was then multiplied by a half Gaussian to simulate
disorder in the sample. (b) The results of a box refinement using the trial
function shown in Fig. 6 a and a Io00-A box. The electron density
profile is characteristic of a repeating unit containing two membranes.
Results using other types of trial functions with boxes from 800 to 1200
A wide were similar.
profiles with and without added Ro 15-1788 are small,
they are significant. To test the validity of the differences,
the integrated intensities of all six orders of diffraction in
both the control and Ro 15-1788-added preparations were
varied randomly by ±10%. Three sets of random varia-
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FIGURE 8 Results of deconvolution of the unit cell Patterson function.
This symmetrized electron density profile was used for determination of
phases. The pointed feature at the center is an artifact due to truncation
of the right half of the original profile at x = 0 A and its reversal to form
the left half of the profile. The Fourier transform of the profile was
calculated and then sampled at intervals of h/d to obtain phases for a
centrosymmetric unit cell (d = 130.7 A).
tions were prepared for each set of diffracted intensities;
electron density profiles were calculated for all. Then the
electron density profile of each control was compared with
every electron density profile in which the drug was
present. In all cases the characteristic differences of the
original electron density profiles were preserved. When
the intensities were varied by ± 15% and the same
procedure was followed, the original differences were still
preserved for most of the comparisons. A 10% intensity
difference is much greater than any error which may
occur during data reduction and analysis; therefore the
characteristic differences must be inherent in the data.
The structure factor curves for lipids with and without Ro
15-1788 are shown in Fig. 11 b. The curves differ signifi-
cantly, especially in the region where s 2 0.09. This is the
region where small changes due to the presence of drug
would be likely to appear.
An estimate of the error in the structure factor was
made by averaging structure factors calculated from data
obtained at two relative humidities at which little struc-
tural change in the membranes was indicated. The largest
variation of the original structure factor curves from the
average was ±2.3%. The largest error in the electron
density profiles then must also be <2.3%, because the
electron density profile is the Fourier transform of the
structure factor. The errors in various regions of the
electron density profile were estimated by calculating the
electron density profile from the average structure factor
at the d spacing of the experimental profile and finding
the difference between it and the experimentally deter-
mined profile. The 5.6% difference between our control
and drug-containing samples is admittedly not much
greater than the estimated error in the electron density
profile; however, the electron density of Ro 15-1788 is
relatively low. Our conclusions are based on the results of
two experiments at each of three relative humidities;
results were clearest at 84% relative humidity.
The structure factors
As part of the swelling study, plots of structure factor vs.
h/d were made for the lipid, lipid plus drug, single
membrane, and single membrane plus drug data sets. (h is
the index of the diffraction order and d is the spacing of
the repeating unit.) For the intact membrane data,
centrosymmetry is only a close approximation to what the
electron micrographs show is a slightly asymmetric struc-
ture (see Fig. 3); thus the structure factors for the single
membrane unit cell are also approximate. The data for
lipid and lipid plus Ro 15-1788 are shown in Fig. 12. All
structure factors were found to lie on very closely related
curves, regardless of whether they were from lipid or
membrane samples, or whether drug had been added.
Data for the two-membrane unit cell did not fall upon the
same curve as the single-membrane data did. The similar-
ity in the curves for lipids and intact single membranes
indicates that the structure seen in our experiments on
intact SNM membranes is due mostly to the lipid bilayer,
and that any changes due to the protein content of the
membrane or to added substances are small. Headgroup
separation across the bilayer varied between -46 A and
-49 A, regardless of the type of preparation involved.
Phases for the first, second, and third orders could be
assigned unambiguously for both membranes and lipids
from the structure factor plots. The structure factors for
the third order of diffraction fall on the curve near a node
which lies at -0.0515 A-'. To determine phases for the
fourth, fifth, and sixth orders for lipids and the fourth and
fifth orders for SNM membranes, all possible phase
combinations were used to calculate electron density
profiles. All phase combinations which gave physically
unreasonable electron density profiles were rejected. Good
electron density profiles were characterized by presence
of a water space region outside the bilayer, lowest electron
density at the center of the methyl trough, a narrow
methyl trough, and a relatively flat acyl chain region.
However, both phase choices for the fifth order gave
acceptable profiles. The following method could not
distinguish the better phase choice: two data sets taken
from the same sample at different relative humidities
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FIGURE 9 Electron density profiles of two-membrane unit cells with and without BAY K 8644. Solid line, control (no drug added), d = 130.7 A.
(Dashed lines) BAY K 8644 added at a final concentration of 3mM (before centrifugation and removal of the supernatant). (Short dashes) d = 129.6
A. (Long dashes) d = 130.0 A. The profiles were calculated by combining experimentally determined intensities with phases obtained by deconvolving
the unit cell Patterson functions, calculating the Fourier transforms of the resulting electron density profiles, and sampling the Fourier transforms at
intervals of h/d. The methyl trough regions of these profiles were scaled to match; because we cannot measure the intensity at h = 0 we have no
absolute electron density scale. Experiments on model membranes have shown that the drug does not penetrate to the methyl trough region.
were chosen. Electron density profiles were calculated
from each data set using each phase choice for the fifth
order. Structure factors were calculated from each elec-
tron density profile and then sampled at the periodicities
of both data sets. When the squares of the structure
factors at those points were compared with the original
intensity data, neither phase choice was better than the
other at matching either the observed relative intensities
of the fourth, fifth, and sixth orders or the change in
intensity of the individual orders between the data sets. A
second method indicated a probable phase of zero for the
fifth order: structure factors were calculated from the
electron density profiles derived from two data sets
obtained from the same sample at adjacent relative
humidities. The structure factors were sampled at the
periodicities of both data sets and electron density profiles
were calculated. The procedure was repeated using the
other phase choice. Then the electron density profiles
were compared to see how closely they resembled one
another. A positive structure factor for the fifth order
gave better results; furthermore, the electron density
profiles had a flatter acyl chain region and better-defined
headgroup and water space regions. The phases chosen
are those represented in the structure factor plot (Fig. 12).
Drug partition coefficients
Partition coefficients (rat SNM membrane/buffer) for
the drugs are given in Table 1, as well as the partition
coefficients of the DHP drugs in rabbit LSR for compari-
son. The partition coefficient was corrected for specific
binding to the benzodiazepine receptor as follows: the
dissociation constant (KD) for Ro 15-1788 in crude
synaptosomal fractions of rat cerebral cortex is 1.0 ± 0.1
nmol/liter; B,, the maximum number of binding sites, is
1.6 ± 0.2 pmol/mg protein (30). These binding data for
the synaptosome preparation were used to approximate
those for the SNM preparation, which is similar. Our
SNM preparation has a phospholipid/protein ratio of
-0.8 ,umol phospholipid/mg protein. All the benzodiaz-
epine binding sites were assumed to be occupied by Ro
15-1788. The counts due to specific binding were sub-
tracted from counts due to total binding, and this differ-
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FIGURE 1o Electron density profiles of two-membrane unit cells with and without Rol5-1788. (Solid line) Control (no drug added), d = 132.0 A.
(Dashed line) Rol5-1788 added at a final concentration of 0.6mM (before centrifugation and removal of the supernatant), d = 131.6 A. The profiles
were calculated by combining experimentally determined intensities with phases obtained by deconvolving the unit cell Patterson functions,
calculating the Fourier transforms of the resulting electron density profiles, and sampling the Fourier transforms at intervals of h/d. These profiles
were scaled using the assumption that the drug causes only a slight perturbation of the electron density profile. The structure factors calculated from
the profiles were scaled to each other to minimize differences; then the profiles were recalculated from the scaled structure factors.
ence was used to calculate Kp. Specific binding of DHP
drugs was insignificant.
The partition coefficients of drugs in LSR were done by
the centrifugation method; all of the partition coefficients
in SNM were done by the filtration method. Our previous
studies have shown that in LSR, there is no difference
between results from the two methods when partition
coefficients for DHP drugs are determined (28).
chain region (31). The data for the two-membrane unit
cell indicate that Ro 15-1788 partitions into the outer
monolayer of the SNM membrane in the upper acyl chain
and phospholipid headgroup regions (Fig. 10). It does not
reach the inner monolayer. The precise locations of the
drugs in the membrane cannot be determined because the
resolution (12 A) is too low.
SNM membrane preparations with
added drugs
The phase determination procedure described above for
the 130-A unit cell was repeated using data obtained from
SNM preparations to which either Ro 15-1788 or BAY K
8644 had been added. The phases determined for the
130-A unit cell data are shown in Table 2.
BAY K 8644 increased electron density primarily in
the outer monolayer of the membrane bilayer from the
headgroup region through the acyl chain region (Fig. 9).
In cardiac sarcolemmal lipid multibilayers, in the absence
of protein, BAY K 8644 partitions into the upper acyl
DISCUSSION
The results reported above represent the first x-ray
diffraction study of SNM membranes from cerebral
cortical tissue. A diffraction pattern from a dispersion of
synaptosomes has been reported by Wilkins et al. (32);
synaptosomes arise from the same type of membrane as
SNM but are prepared differently (33).
The small amounts of myelin that were apparent in the
electron micrographs of the SNM preparations were of
concern because myelin diffracts x-rays very well, al-
though an immunoassay for myelin basic protein showed
that < 2% by weight of the total membrane in the SNM
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FIGURE 11 Ro 15-1788 in extracted SNM membrane lipids. (a) Comparison of electron density profiles of spin-dried rat SNM lipids at 84% relative
humidity and 10.0°C. (Solid curve) No drug added, d = 55.3 A; (Dashed curve) 1 mol Rol5-1788:30 mol lipid, d = 54.0 A. The arrow indicates an
increase in electron density. (b) Structure factors calculated from the electron density profiles in Fig. 11 a. (Solid curve) No drug added, d - 55.3 A;
(dashed curve) 1 mol Ro 15-1788:30 mol lipid, d = 54.0 A. The differences are greatest in the region, where s ; 0.09, the region corresponding to the
location of sixth order of diffraction.
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FIGURE 12 Experimental structure factor curve. Structure factors for SNM extracted lipids without added drug (stars), and for lipids with added Ro
15-1788 (boxes). The drug/lipid mole ratio is 1:30. The curve shown is a spline fit to the control data (stars) with the phases chosen as described in the
text. The opposite phase choice for the fifth order (negative structure factor) also produced a reasonable electron density profile (see Results). Data for
lipids with added drug are shown to illustrate that the curves are similar, but do not coincide.
preparation is myelin. The d spacing for myelin in intact
nerve fibers is 150-180 A, corresponding to the thickness
of two membranes (24). At low relative humidity, the d
TABLE 1 Partition coefficlents of
lmidazobenzodiazepine and dlhydropyridine drugs
Kp(SNM
Drug lipid extract) K,(LSR*)
BAY K 8644 1,093 (±380)t 11,000 (31)
Nimodipine 1,100 (±220)t 5,000 (7, 28)
Ro 15-1788 37 (±47)$a 17 (±17)t
*LSR = rabbit light sarcoplasmic reticulum.
tThis work. Numbers in parentheses are standard deviations.
aGrand mean of 18 determinations (n = 3).
TABLE 2 Phases for data from the two-member unit
cell
Order
Sample type 1 2 3 4 5 6 7 8 9 10 11
Controls 0 0 0 0 0 0 0 0 xr 7r ir
BAY K8644 0 0 0 0 0 0 0 0 ir r ir
Ro l5-1788 ir 0 0 0 0 0 0 0 ir 7r
spacing of our SNM preparation is only 130 A. None of
our SNM preparations exhibited such a large d spacing at
high relative humidity. Sedzik et al. obtained a d spacing
of 74-76 A for preparations of isolated myelin (1 1). This
d spacing is comparable to that calculated for the SNM
preparations. A weak ring of Bragg-like diffraction corre-
sponding to a d spacing of 76 A appeared in diffraction
from dispersions of vesicles. The ring would be due to
multilamellar vesicles or to multilamellar fragments of
membrane, possibly myelin. Because of its innate order, a
small amount of multilamellar material in a suspension of
vesicles would diffract much more strongly than unilamel-
lar vesicles at a similar concentration. Diffraction results
using multilayer, oriented samples of myelin-free shiverer
mouse SNM were indistinguishable from those from rat
SNM. Therefore, diffraction due to myelin, if any, is
unlikely to affect significantly the diffraction pattern from
our SNM multilayer samples.
Structure of SNM membranes
We were unable to determine phases for the single-
membrane unit cell data by method of Blaurock and King
(13) because we obtained only low-resolution results from
diffraction experiments on dispersions of SNM mem-
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brane vesicles. Nevertheless, assumption ofcentrosymme-
try gives a close approximation of the structure (see
Results) and is useful for comparisons among data sets.
The electron density profiles (calculated assuming cen-
trosymmetry of the membrane) and diffraction patterns
of SNM are typical of those of biological membranes
containing protein, with d spacings in the range 71-87 A,
depending on the hydration state of the membrane.
Analysis of the data for the 130-A unit cell yields a unit
cell containing two membranes (Fig. 9); the individual
membranes are somewhat asymmetric. The outer surface
of the bilayer contains more protein and therefore has a
lower electron density than the inner surface. This differ-
ence in protein content is confirmed by high-magnifica-
tion electron micrographs of SNM; the outer monolayer
of the membrane is more densely stained than the inner
monolayer (Fig. 3). When the relative humidity is low-
ered sufficiently, each collapsed membrane vesicle forms a
single unit cell containing two back-to-back membranes.
Thus the unit cell is likely to be centrosymmetric.
Data for the single- and double-membrane unit cells do
not fall on the same structure factor squared curve. This is
further confirmation that the membranes are stacked in
groups of two and not stacked randomly. In the case of
random stacking, the new two-membrane unit cell at low
relative humidities would not appear, and the squared
structure factors would continue to lie on the same curve.
The change in diffraction pattern occurs suddenly within
a narrow range of relative humidities and is completely
reversible. We explain this sudden d space change as
follows: at higher hydration states, water obscures the
regular stacking pattern of the asymmetric membranes
by "diluting" the protein, glycosylation, etc. present at
the outer surfaces of the membranes so that the unit cell
represents the averaged structures of the asymmetric
single membrane. Removal of enough water results in an
electron density contrast that causes these surface fea-
tures to affect the diffraction pattern, requiring a new,
two-membrane repeating unit which is centrosymmetric.
The single membrane, in which this contrast is low, is
unlikely to be highly asymmetric; if it were, the unit cell
at higher hydration states would probably contain two
membranes.
Molecular interaction of drugs with
SNM membranes and membrane
lipids
Lipid extracts
The presence of protein in the membrane is a source of
some disorder in the membrane multilayer stack; various
kinds of protein can also interact with the drug, specifi-
cally or nonspecifically. Control of the exact concentra-
tion of the drug in the membrane multilayer diffraction
sample is also impossible, as the supernatant, which
contains some of the added drug, is removed after
centrifugation of the diffraction sample. Extracted lipids
are a simpler system, and the results are more easily
interpretable. Furthermore, because the lipid bilayer
must be centrosymmetric, accurate phasing is possible.
The drug concentration can be precisely controlled by
using the "spin-dry" technique (22), in which all volatile
fluids are dried off under vacuum during centrifugation.
Afterward, the multibilayer, containing all of the added
drug, is partially rehydrated. This technique is too harsh
for intact membranes because it can cause phase separa-
tion. For these reasons, we conducted diffraction experi-
ments on lipids extracted from SNM membranes in the
hope of clarifying the interactions of the drugs with intact
membrane.
In the diffraction experiments on extracted lipids, an
electron density increase appeared in the upper acyl chain
region of the electron density profile of the lipids with
added Ro 15-1788 (arrow, Fig. 11). We attribute this
electron density to the presence of the drug. Only a small
electron density increase would be expected because Ro
15-1788 has only a ring system and a single fluorine atom
to raise its electron density relative to the bilayer and
increase the contrast. Ro 15-1788 crystallizes in a tetrag-
onal unit cell of 2697 A3 vol, Z = 8 (34). From the crystal
data and chemical formula, its electron density is 0.469
e-A-3. The electron densities of the headgroup, glycerol
backbone, and acyl chain regions of a pure DPPC bilayer
are 0.46, 0.42, and 0.26 e-A 3, respectively (35). These
electron densities roughly approximate those of the ex-
tracted lipid bilayer. If the drug is located in the head-
group region and occupies approximately the space of a
lipid molecule, then it may have low contrast in that
region, and also possibly in the glycerol backbone region.
Electron density contrast due to Ro 15-1788 located in the
acyl chain region would be more likely to show up, and
indeed, that is what appears. The presence of the drug
appears to widen the methyl trough region somewhat,
indicating some disordering of the acyl chains. Our results
show that the drug binds nonspecifically in the upper acyl
chain region in the absence of protein, but the headgroup
and glycerol backbone regions are not ruled out.
Partition coefficients and drug interaction
with intact SNM membranes
When BAY K 8644 is added to the SNM preparation, it
increases the electron density primarily in the outer
monolayer of the membrane. BAY K 8644 appears to
interact at the headgroup region through the upper acyl
chain region (Fig. 9), probably with the protein located
there. Some BAY K 8644 penetrates to the inner mono-
layer of the membrane. BAY K 8644 seems to impart
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order to the diffraction sample and often delays phase
separation; our highest quality data on the 130-A unit cell
were obtained from samples containing BAY K 8644. In
intact membrane, Ro 15-1788 interacts with the head-
group region, but unlike BAY K 8644, it does not appear
to reach the inner monolayer of the membrane at all
(Fig. 10). This behavior indicates a surface interaction
with the membrane protein. Our preliminary data show
that the partition coefficient of Ro 15-1788 in intact SNM
membranes is somewhat higher than in SNM lipid
extracts. The higher partition coefficient in the presence
of protein supports a nonspecific surface interaction with
membrane protein. The decrease in electron density at the
center of the vesicle in the drug-containing sample rela-
tive to the control is probably due to the smaller water
space in the control. These results are preliminary; the
contrast of these drugs with the membrane in x-ray
diffraction experiments is low. Analogous neutron diffrac-
tion experiments using deuterated drugs, which will
provide better contrast, are planned.
In Table 1 membrane/buffer partition coefficients of
DHP's are given for LSR as well as for SNM. In LSR, the
partition coefficients of the DHP's are increased approxi-
mately threefold over those in SNM. The reason for this
increase might be the differences in cholesterol content of
the two types of membrane. We found that the cholesterol/
phospholipid mole ratio in our lipid extracts of rat brain
SNM membranes was 0.7; in extracts of rabbit skeletal
muscle LSR the mole ratio was only 0.06. Cholesterol
positions itself in the membrane lipids in the region of the
hydrocarbon core which is just below the glycerol back-
bone, with the cholesterol molecule oriented parallel to
the hydrocarbon chains (36). A high concentration of
cholesterol may tend to exclude drugs from the upper
portion of the acyl chain region, which is the area into
which the DHP's normally partition. When the DHP
calcium channel antagonist nimodipine was introduced
into dioleolylphosphatidylcholine (DOPC) lipid bilayers
containing 0.30 mol of cholesterol per mole of phospho-
lipid, the partition coefficient of the drug was reduced to
half its value in DOPC bilayers containing no cholesterol.
Higher cholesterol concentrations produced even further
lowering of the partition coefficient. By this reasoning the
partition coefficients of DHP's in SNM would be lower
than those in LSR, if the interaction is with the hydrocar-
bon core of the membrane bilayer.
The imidazobenzodiazepines, which appear to interact
with the membrane surface and headgroup region in
intact membrane, are less affected by the higher choles-
terol content ofSNM.
Rhodes et al. (37) calculated the kinetics of approach
of DHP drugs to their binding site on the Ca2+ channel in
cardiac sarcolemmal membrane. Two models were used.
The first was direct approach of the drug to its binding site
through the aqueous medium. The second was approach
of the drug through the membrane, a two-step mechanism
in which the drug first partitions somewhere into the
membrane bilayer and then diffuses laterally to its bind-
ing site. The first model requires that the binding site be in
contact with the aqueous medium. In the second model,
the binding site must be located at the preferred -nonspe-
cific binding depth of the drug in the membrane. Other-
wise the drug will not contact its binding site during
diffusion (28). The calculated diffusion-limited rate of
approach for the membrane approach model was found to
be three orders of magnitude greater than that for the
aqueous approach model.
It is likely that the membrane approach to the binding
site is an efficient one for both the imidazobenzodiaz-
epines and the dihydropyridines. It appears that Ro
15-1788 is located in the phospholipid headgroup region
through the upper acyl chain region in the intact mem-
brane and possibly also in the extracted lipid bilayer. We
expect the benzodiazepine receptor site to be located on
the GABAA/benzodiazepine receptor complex some-
where near the surface of the membrane bilayer, so that
the drug diffusing through the hydrophilic region of the
membrane would eventually come into contact with its
specific binding site on the receptor protein.
Summary and implications
of the work
Electron microscopy and x-ray diffraction showed that
the SNM membrane is somewhat asymmetric. X-Ray
diffraction experiments indicated that the imidazobenzo-
diazepine Ro 15-1788 and the DHP BAY K 8644
partition into the intact membrane in the region from the
headgroup through the upper part of the acyl chains. Both
drugs appear to be located primarily in the outer mono-
layer of the membrane; Ro 15-1788 appears not to enter
the inner monolayer at all; it interacts strongly with the
membrane protein in intact SNM membrane. These
experiments are preliminary to planned experiments us-
ing neutron diffraction with deuterated drugs for better
contrast. Partition coefficients for DHP drugs are approx-
imately fivefold higher in LSR than in SNM. This
difference is possibly attributable to the higher cholesterol
content of SNM compared with LSR. Both the DHP's
and imidazobenzodiazepines are likely to approach their
specific binding sites on membrane receptor proteins via a
two-step membrane pathway rather than by an aqueous
route. Neutron scattering experiments have shown that
ethanol partitions into LSR primarily throughout the
aqueous region of the membrane (the headgroup and
glycerol backbone region) and is excluded from the
hydrocarbon core (38). Ro 15-1788 partitions into the
aqueous region of the SNM membrane. The imidazoben-
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zodiazepines, then, would be likely to interact directly
with ethanol and with their specific binding sites on the
receptor protein in the headgroup/glycerol backbone
region of the membrane. This hypothesis is consistent
with the antagonism by Ro 15-4513 of some of the
behavioral intoxicating effects of acute ethanol adminis-
tration, and of its selective antagonism of ethanol-related
increase in GABA-mediated chloride flux (2, 3).
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